Who founded Evolvere BioSciences?

Evolvere BioSciences was founded by Adam Winnifrith, Piotr Jedryszek, Weronika Slesak in 2021.

Who are Evolvere BioSciences's investors?

Evolvere BioSciences's investors include Y Combinator.

Where is Evolvere BioSciences headquartered?

Evolvere BioSciences is headquartered in Oxford, GB.

Evolvere BioSciences

YC S24

Oxford, GB · Founded 2021 · 3 employees · 1 known investors

Find your way into Evolvere BioSciences

346 people in our graph share verified history with the Evolvere BioSciences team — schools, employers, funds. One of them is your warm intro.

Mariaunlockedknows Piotr Jedryszek · together at University of Oxford (overlapped)

×9knows the team · via University of Oxford

knows the team · via Institut Pasteur

knows the team · via Weizmann Institute of Science

Evolvere BioSciences develops antibiotics using computational models and evolutionary data to target pathogenic bacteria while preserving beneficial microbes, designed to resist the development of bacterial resistance.

AI & Machine Learning Biotech Healthtech AI-powered Drug Discovery Artificial Intelligence Therapeutics BiotechnologyUnited KingdomEurope

Founders & leadership· Y Combinator alumni (S24)

Evolvere BioSciences was founded in 2021 by Adam Winnifrith, Piotr Jedryszek, and Weronika Slesak.

Adam Winnifrith inFounderAdam Winnifrith holds a degree in biochemistry from Oxford and is CEO and co-founder of Evolvere BioSciences, where he works on bioengineering, protein AI, and automation technologies.

Piotr Jedryszek inFounderPiotr Jedryszek is co-founder and CTO of Evolvere BioSciences, with a background in biology and computational biology.

Weronika Slesak inFounderWeronika Slesak is a biologist educated at Oxford who currently serves as Chief Scientific Officer at Evolvere BioSciences, where she applies evolutionary principles to bioengineering.

Investors · 1

Y CombinatorSan Francisco · $500K

Frequently asked questions

What does Evolvere BioSciences do?: Evolvere BioSciences develops antibiotics using computational models and evolutionary data to target pathogenic bacteria while preserving beneficial microbes, designed to resist the development of bacterial resistance.
Who founded Evolvere BioSciences?: Evolvere BioSciences was founded by Adam Winnifrith, Piotr Jedryszek, Weronika Slesak in 2021.
Who are Evolvere BioSciences's investors?: Evolvere BioSciences's investors include Y Combinator.
Where is Evolvere BioSciences headquartered?: Evolvere BioSciences is headquartered in Oxford, GB.